XML 61 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets
9 Months Ended
Sep. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2022$39,752 
Adjustments due to finalization of purchase price allocations(2)
Foreign currency translation and other(595)
Balance, September 29, 2023$39,155 
The carrying value of goodwill by segment is summarized as follows ($ in millions):
September 29, 2023December 31, 2022
Biotechnology$21,643 $22,087 
Life Sciences8,227 8,314 
Diagnostics6,805 6,875 
Environmental & Applied Solutions2,480 2,476 
Total$39,155 $39,752 
The Company has not identified any “triggering” events which indicate an impairment of goodwill in 2023.
The Company reviews identified intangible assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company identified impairment triggers during the second and third quarters of 2023 and the second quarter of 2022 which resulted in the impairment charges of certain long-lived assets, including technology, customer relationships and trade names. The Company recorded impairment charges totaling $6 million and $40 million in the three and nine-month periods ended September 29, 2023, respectively, and $9 million in the nine-month period ended September 30, 2022 related to these long-lived assets. In addition, during the nine-month period ended September 29, 2023, the Company recorded a $14 million impairment related to a facility.